Beta Bionics Inc. (BBNX)
NASDAQ: BBNX
· Real-Time Price · USD
17.07
0.36 (2.15%)
At close: Aug 15, 2025, 2:18 PM
Beta Bionics Balance Sheet Statement
Financials in USD. Fiscal
year is
undefined.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
Cash & Equivalents | 35.08M | 42.45M | 30.43M | 17.48M | n/a | 26.57M |
Short-Term Investments | 214.65M | 189.02M | 73.14M | 43.42M | n/a | 70.18M |
Long-Term Investments | 31.15M | 64M | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 244K | 246K | 5.3M | 3.35M | n/a | 221K |
Receivables | 11.39M | 11.01M | 12M | 7.46M | n/a | 4.45M |
Inventory | 17.32M | 15.73M | 13.32M | 11.29M | n/a | 1.25M |
Other Current Assets | 7.64M | 260K | 1.05M | 305K | -96.75M | 275K |
Total Current Assets | 286.07M | 261.92M | 132.92M | 82.56M | n/a | 103.62M |
Property-Plant & Equipment | 12.5M | 11.86M | 11.42M | 11.04M | n/a | 6.2M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 43.9M | 76.11M | 16.72M | 14.38M | n/a | 6.42M |
Total Assets | 329.97M | 338.02M | 149.65M | 96.94M | n/a | 110.04M |
Account Payables | 3.42M | 3.45M | 2.85M | 2.85M | n/a | 1.17M |
Deferred Revenue | 1.14M | 949K | 939K | n/a | n/a | n/a |
Short-Term Debt | 1.52M | 1.52M | 1.53M | 1.45M | n/a | n/a |
Other Current Liabilities | 5.78M | 4.92M | 9.41M | 672K | n/a | 1.14M |
Total Current Liabilities | 19.49M | 16.49M | 21.15M | 17.88M | n/a | 10.61M |
Long-Term Debt | 5.17M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 3.68M | 2.33M | 44.9M | 38.88M | -58.61M | 37.83M |
Total Long-Term Liabilities | 8.85M | 7.78M | 52.48M | 46.19M | -58.61M | 40.83M |
Total Liabilities | 28.34M | 24.27M | 73.63M | 64.07M | -58.61M | 51.43M |
Total Debt | 6.69M | 6.97M | 7.25M | 7.3M | n/a | 4.22M |
Common Stock | 4K | 4K | 1K | 1K | n/a | 1K |
Retained Earnings | -342.26M | -325.39M | -296.74M | -278.63M | n/a | -229.66M |
Comprehensive Income | 149K | 240K | 65K | 58K | -203.1M | 137K |
Shareholders Equity | 301.63M | 313.75M | 76.01M | 32.87M | 58.61M | 58.61M |
Total Investments | 245.79M | 253.02M | 73.14M | 43.42M | n/a | 70.18M |